Objective: The aim of this study was to identify the mechanism responsible for an increase in miniature endplate potentials (MEPPs) amplitude, induced by ryanodine as an agonist of ryanodine receptors in mouse motor nerve terminals.
| INTRODUC TI ON
Recently, we have found that ryanodine-stimulated calcium release from intracellular calcium stores initiates a calcium-dependent increase in MEPP amplitude and ACh quantal size in mouse neuromuscular junctions (NMJs) (Skiteva, Lapteva, & Balezina, 2012) . Both the mechanism of this ryanodine effect and possible ryanodine influence on the multiquantal evoked ACh release remain unknown.
Currently, several substances are known to increase the MEPPs amplitude when exogenously applied to mammalian motor synapses:
γ-S-ATP (Bogacheva & Balezina, 2015) , TGF-β2 (Fong et al., 2010) , agonists of endocannabinoid receptors (Morsch et al., 2018) , BDNF (Gaydukov, Akutin, Bogacheva, & Balezina, 2018) , calcitonin generelated peptide (CGRP) (Gaydukov, Bogacheva, & Balezina, 2016) . Of these, CGRP is of special interest because this 37-amino acid neuropeptide has been found in large dense-core vesicles (LDCVs) in mammalian motor nerve terminals (Csillik et al., 1993; Matteoli et al., 1988) and is reported to be released as a co-transmitter in response to sustained depolarization or intense nerve stimulation (Sakaguchi, Inaishi, Kashihara, & Kuno, 1991; Sala, Andreose, Fumagalli, & Lømo, 1995; Uchida et al., 1990) providing the wide spectrum of acute and neurotrophic influences (Buffelli, Pasino, & Cangiano, 2001; Changeux, Duclert, & Sekine, 1992; Correia-de-Sá & Ribeiro, 1994; Fernandez, Ross, & Nadelhaft, 1999; Kimura, Okazaki, & Nojima, 1997; Machado et al., 2016; Rossi, Dickerson, & Rotundo, 2003; Salim, Dezaki, Tsuneki, Abdel-Zaher, & Kimura, 1998) . Possible release of endogenous CGRP in response to ryanodine application at resting motor synapses and acute physiological consequences of this release on quantal ACh secretion have not been described yet. The aim of this study was to test the hypothesis that ryanodine can trigger calcium-dependent release of CGRP from motor nerve terminals of mice and further presynaptic action of endogenous peptide may underlie the increase in MEPP amplitude and ACh quantal size.
We found that the ryanodine-induced increase in MEPP amplitude and ACh quantal size is associated with the release of endogenous CGRP. Using pharmacological assays, we also provide evidence of specific role of presynaptic CaMKII, whose activation and leads to exocytosis of endogenous CGRP from mouse NMJ. We also found for the first time that endogenous CGRP, which was released into synaptic cleft of motor synapses, may act presynaptically stimulating the loading of ACh into synaptic vesicles.
| ME THODS AND MATERIAL S

| Preparation and solutions
Experiments were performed with classical neuromuscular preparations (diaphragm muscle supplied with phrenic nerve) isolated from adult BALB/c mice of either sex (25-30 g) 5-6 weeks old. The animals were obtained from the Laboratory of experimental animals, Department of Biology, Moscow State University (Moscow, Russia), and were kept according with the European Communities Council Directive from 24 November 1986 (86/609/EEC). All experimental procedures were approved by the Bioethics Committee of The Department of Biology at Moscow State University. The mice were sacrificed by quick decapitation. Left hemidiaphragm with the terminal branches of phrenic nerve was excised, mounted to a 3-ml recording chamber, and superfused with Liley solution (mM: NaCl-135, KCl-4, NaH 2 PO 4 -0.9, CaCl 2 -2, MgCl 2 -1, NaHCO 3 -16.3, glucose-11, pH-7.2-7.4 , gassed with 95% O 2 /5% CO 2 ) via bath perfusion system (0.5 ml/min). All experiments were performed at room temperature (20-22°C).
| Electrophysiological recordings
Intracellular recordings of endplate potentials (MEPPs and EPPs) were performed using sharp glass microelectrodes filled with 2.5 M KCl. Tip resistance of microelectrodes was 20-25 MΩ. Appearance of MEPPs with rise time (10%-90%) <1 ms was indicative of the muscle fiber impalement near endplate region. We recorded MEPPs for 180 s from muscle fibers with resting membrane potential (RMP) more negative than −60 mV. RMP was continuously monitored throughout the MEPP recordings in each synapse. If the value of RMP was not stable and decreased by more than 5 mV, the recording was stopped and the data acquired from this synapse were not included into the sample population for further analysis. Bridge balance and microelectrode capacitance neutralization was performed throughout the entire experiment.
Experiments on ACh multiquantal synchronous release evoked by stimulation of phrenic nerve were performed with cut neuromuscular preparations to prevent contraction as well as to record both MEPPs and EPPs from the same synapse (Barstad & Lilleheil, 1968) . After the dissection of the fibers, the preparation was washed thoroughly for at least 1 hr in a large volume of the Liley solution (>150 ml). This procedure prevented the blockage of the action potential conduction. RMP was stabilized at a lower level (<−50 mV) than in intact fibers. Cutting of the fibers was not performed in preparations when only spontaneous ACh release was recorded. The phrenic nerve was stimulated with suprathreshold stimuli at a frequency of 0.3 Hz and with duration of 0.08-0.1 ms using two silver electrodes connected with an STG4002 stimulator (Multichannel Systems GmbH, Reutlingen, Germany). At least 30 EPPs were re- In each experimental series, at least three neuromuscular preparations were used. MEPPs (or MEPPs and EPPs) from 5 or more different synapses were recorded as control. After that, the perfusion solution was changed to the drug-containing test solutions and synaptic activity of various synapses was recorded for 0.5-1.5 hr.
| Data analysis
We estimated RMP of muscle fibers, MEPP and EPP amplitude and The MEPP and EPP amplitudes were standardized to the membrane potential of -50 mV when evoked synaptic activity was studied using cut muscle fibers (Flink & Atchison, 2003) . Quantal content of EPP was calculated as a ratio between the mean standardized EPP amplitude corrected to nonlinear summation (McLachlan & Martin, 1981) and the mean standardized MEPP amplitude.
Data are presented as the mean ± SEM; n reflects number of the synapses analyzed. Statistical significance between sample means was assessed using Student's t-test (in the case of normal distribution), one-way analysis of variance ANOVA, or Mann-Whitney test (when cumulative probabilities of MEPP amplitudes were analyzed).
The difference was considered significant at p < 0.05.
| Chemicals
All drugs were diluted to a final concentration in Liley solution. CGRP (rat peptide isoform which shares the same amino acid sequence with endogenous mouse peptide) and inhibitor of CGRP-receptors-rat 
| RE SULTS
In the first series of experiments, we used the prolonged stimulation (for 90 min) of calcium release from intraterminal stores using application of ryanodine at submicromolar concentration (0.1 μM)
as RyR activator (Balezina, 2002; Gerasimova et al., 2015; Zucchi & Ronca-Testoni, 1997 This potentiating effect of ryanodine definitely resembled the action of exogenous CGRP on MEPPs and EPPs amplitudes that we recently described in mouse diaphragm synapses (Gaydukov et al., 2016) . Similar to ryanodine, application of exogenous CGRP (10 nM) induced an increase in the MEPPs amplitude of the MEPPs up to 130.6 ± 9.6% (p < 0.05) (Figure 3a ) without changing muscle fibers RMP, and the time parameters or frequency of MEPPs. The cumulative probability plots revealed a shift toward the larger amplitudes under CGRP, as in the case of ryanodine (Figure 3b ). On the other hand, the effect of the exogenous peptide required less time to develop (within 30-40 min of application) than the analogous effect of ryanodine.
In our previous report, we have demonstrated that potentiating action of ryanodine on MEPPs amplitude was prevented by loading the nerve terminal with Ca 2+ chelator EGTA-AM suggesting that an increase in MEPPs amplitude under ryanodine is calcium dependent (Skiteva et al., 2012) . We hypothesized that the release of stored calcium by ryanodine may selectively stimulate the exocytosis of CGRP-containing LDCVs, which will be followed by the increase in MEPP amplitude as the result of activation of CGRP receptors by released endogenous CGRP. To test this hypothesis, we studied the action of 0.1 μM of ryanodine in the presence of truncated CGRP (CGRP 8-37 , 1 μM) which is widely used as CGRP-receptor blocker (Gaydukov et al., 2016; Han, Adwanikar, Li, Ji, & Neugebauer, 2010; Hay, Garelja, Poyner, & Walker, 2017; Wu et al., 2015) . We have shown that CGRP 8-37 alone had no significant effect on MEPP amplitude (Gaydukov et al., 2016) . Nevertheless, when CGRP-receptors were blocked, application of ryanodine (0.1 μM) did not significantly change the amplitude of MEPPs (Figure 3c,d ). These data suggest that ryanodine initiates calcium-dependent release of endogenous CGRP, which, in turn, potentiates MEPP amplitude. If it is the case, the mechanism that underlies the increase in MEPP amplitude by endogenous CGRP must be the same as for the exogenously applied peptide. As we have shown recently, this mechanism includes the presynaptic action of CGRP which stimulates ACh transport into synaptic vesicles and increases ACh quantal size (Gaydukov et al., 2016) .
Taking into account these arguments, we next examined whether vesamicol (direct inhibitor of vesicular ACh transporter) may counteract the effect of ryanodine. In our previous studies, we have shown that vesamicol by itself has no significant effect on MEPP amplitude (Gaydukov & Balezina, 2006; Gaydukov et al., 2016) . However, appli- we tested the effect of ryanodine in the presence of PKA inhibitor H-89 (1 μM). We found that 0.1 μM ryanodine was not able to increase the MEPP amplitude when PKA is inhibited (Figure 4c,d ).
Altogether, these results suggest that the stimulation of stored calcium release in mouse motor synapses may provoke exocytosis of endogenous CGRP which, like exogenous CGRP, increases MEPP amplitude via quantal size upregulation.
One question remained unresolved-how the endogenous CGRP exocytosis is mediated after calcium release from presynaptic ryanodine-sensitive calcium stores? At Drosophila NMJs, it was suggested that calcium release from presynaptic endoplasmic reticulum activates CaMKII which, in turn, facilitates the mobilization and secretion of LDCVs (Shakiryanova et al., 2007) . We investigated whether this protein kinase in mouse motor synapses can mediate the effect of ryanodine and participate in the release of endogenous CGRP which increases MEPP amplitude. We tested the effects of 
| D ISCUSS I ON
The present study revealed that ryanodine action in motor synapses of mice can initiate an increase in postsynaptic potentials amplitude due to presynaptic action of endogenous CGRP. The At present, the mechanisms leading to effective and selective release of endogenous CGRP in motor synapses and the spectrum of its acute effects remain poorly understood. Previously, some attempts were made to evoke the exocytosis of endogenous CGRP in various NMJs using high external K + concentration (Sakaguchi et al., 1991; Van der Kloot et al., 1998) or high-frequency nerve stimulation (Kimura et al., 1997; Sala et al., 1995) . It has been shown that endogenous peptide after its release could change membrane or metabolic characteristics of muscle fibers (Macdonald, Nielsen, & Clausen, 2008; Sala et al., 1995; Uchida et al., 1990) . In our study, another procedure was used to stimulate selectively the release of endogenous CGRP-prolonged stimulation of stored calcium release by ryanodine as agonist of RyRs. It is well-known that ryanodine at submicromolar concentrations locks the RyRs in open configuration but with reduced conductivity and thus promoting leakage of calcium from the stores (Clarke & Hendrickson, 2016; Nagasaki & Fleischer, 1988 (mediated by endogenous CGRP). In the latter case, about 1.5 hr from the start of ryanodine application is required for the detection of a significant increase in MEPPs amplitude. There may be a number of several reasons for this discrepancy. First, the LDCV exocytosis proceeds more slowly than the exocytosis of small synaptic vesicles with conventional neurotransmitter (Wong, Cavolo, & Levitan, 2015; Xia, Lessmann, & Martin, 2009) . Secondly, as we have shown, the release (leakage) of calcium from calcium stores with the subsequent activation of CaMKII is required to trigger the exocytosis of LDCVs, which in total also requires a certain time. Finally, it has been shown that the size of LDCV pool in motor nerve terminals is relatively small (Kashihara, Sakaguchi, & Kuno, 1989; Pécot-Dechavassine & Brouard, 1997 and release. It has been reported that CGRP is neurogenic and is released from motor nerve terminals in different tissues (Uchida et al., 1990; Sakaguchi et al., 1991; Macdonald et al., 2008; Iyengar et al. 2017) . Thus, it looks more likely that ryanodine application to motor synapses initiates calcium release from presynaptic Ca 2+ -stores leading to secretion of endogenous CGRP from motor nerve terminals followed by an increase in MEPPs amplitude in motor synapses.
In addition to the well-known neurotrophic effects of CGRP aimed to maintain the properties of skeletal muscle fibers, a new form of endogenous CGRP activity in motor synapses is revealed. We found for the first time that endogenous CGRP, which is released in the synaptic cleft due to the activation of ryanodine sensitive 
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